title: Resolution of Crohn's (Johne's) disease with antibiotics: what are the next steps?
authors.affiliation: a Department of Microbiology and Pathology , Washington State University , Pullman , WA , USA.
authors.forename: William C
authors.initials: WC
authors.lastname: Davis
authors.affiliation: b Clinical Laboratories and Clinical Pathology , Temple University Hospital , Philadelphia , PA , USA.
authors.forename: J Todd
authors.initials: JT
authors.lastname: Kuenstner
authors.affiliation: c Microbiology Laboratory, Animal Health Division , Central Institute for Research on Goats , Mathura , India.
authors.forename: Shoor Vir
authors.initials: SV
authors.lastname: Singh
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D016927:Mycobacterium avium subsp. paratuberculosis / Q000187:drug effects* / Q000472:pathogenicity; D010283:Paratuberculosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000635:transmission; D012307:Risk Factors; D016896:Treatment Outcome; D015047:Zoonoses / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000635:transmission
chemical_list: D000900:Anti-Bacterial Agents
keywords: Crohn’s disease; Johne’s disease; Mycobacterium avium subsp paratuberculosis; mycobacteium tuberculois; zoonotic